H-2-restricting haplotype selected different LCMV proteins for CTL recognition epitopes and that the GP in H-2b mice induced a prominent (N33% of the total) CTL response (23) . Further dissection of the GP recognition sites in H-2b (C57BL/6) mice using a series of LCMV ARM GP cDNA deletions from the 3' end indicated that the vast majority of H-2b LCMV CTL clones (17 of 18 : 94%) recognized GP, and 1 (6%) NP (23, 24) . Further, the majority of GP CTL clones, 15/17 (88%), recognized targets expressing GP as 272-293 (Table I ). Here we report using five of these CTL clones, 232, 228, 31, RG-9, and 39, a battery of truncated peptides from GP as 272-293 region, and site-specific amino acid substitutions to precisely identify and map the fine structure of the CTL epitope .
Materials and Methods
Target Cells, Viruses, and Mouse Strains. BALB/c clone (Cl) 7 (K' Id Dd), B10 .3R (KbIbD'), B10.4R (KkIkDb), and B10 .5R (KllbDd) cells were grown in MEM supplement with 10% heat-inactivated FCS, 104 U of penicillin/ml, 10 mg of streptomycin/ml, and 1 MM r.-glutamine, while MC57 (KbIbDb) cells were grown in RPMI 1640 supplemented as above . Viruses used have been described previously (11, 23, 24) and consisted ofLCMV ARM clone 53b, recombinant vaccinia virus:LCMV GP cDNA vectors expressing LCMV GP as 1-363, 1-293, 1-271, 1-218, and vaccinia virus:LCMV NP cDNA vectors expressing LCMV NP 1-558 . BALB/WEHI (W) (H-2d) and C57BL/6 (H-26) mice were obtained from the closed vivarium breeding colony at the Research Institute of Scripps Clinic .
CTL Clones. Specific CTL clones (H-26) were generated from C57BL/6 mice and maintained in culture as previously detailed (24) . CTL clones were virus specific in that they failed to lyse target cells infected with vaccinia virus alone and H-2 restricted as they lysed H-26 but not H-2d targets infected with LCMV The specificity of the clones used for experimentation are shown in Table I . CTL clones were used in E/T ratios of 5 :1 and 2.5:1.
Primary Day 6-7 Splenic CTL. LCMVspecific CTL were induced by intraperitoneal injection of 2 x 105 PFU of virus. Spleens were harvested 6-7 d after inoculation. Primary vaccinia CTL were induced by intraperitoneal inoculation of 2 x 106 PFU of virus, with harvesting on the 6th day. Single cell suspensions, free of erythrocytes, were used at E/T ratios of 50:1 and 25:1 (11, 24) . Cytotoxic Assays. Killing by CTL was quantitated using a 4-5-h "Cr-release assay as described (11, 24) . Target cell numbers used per assay point were 2 x 104. Samples were processed in triplicate and standard deviation among triplicates was <7%.
Peptide Synthesis. Peptides were synthesized by the solid phase method described by Merrifield (25) with an automated peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster City, CA) or by the tea bag method of Houghten (26) . Peptides were cleaved from their insoluble polystyrene resin beads byhydrogen fluoride, extracted, lyophilized, and analyzed for purity by HPLC. Unless stated otherwise in the text, peptide, solubilized in RPMI, was incubated at a final concentration of 200 gg/ml with uninfected target cells throughout the 4-5-h period of the cytotoxic assay.
Results
A Major Lymphocytic Choriomeningitis Viral Epitope Restricted by H-26 Haplotype Resides in the Glycopmtein between as Residues 272-293. A peptide encompassing LCMV ARM GP as 272-293 I.SDSSGVENPGGYCLTKWMILA was synthesized, and its activity was analyzed. When 200 pg/ml of peptide was used to coat H-2b cells, these targets were lysed in an LCMV peptide-specific and H-2-restricted manner by LCMV CTL clones (specific "Cr released by clone 232: 62%, by clone 228: 40%) that recognize the major GP CTL epitope but not by the CTL clone (2-1 : 7 %) that recog- In brief, the LCMV GP gene was serially truncated from the Tend and attached to translational termination sequences . The restriction enzymes used were Bgl II, Pst I, Tthl III, and Dra III which, respectively, generated COOH terminally truncated GP molecules comprising residues 1-363, 1-293, 1-271, and 1-218 . These cDNA clones, and a full-length LCMV NP clone, were introduced into vaccinia virus by standard methods . In all cases, Northern blot analyses have confirmed the expression from the recombinant vaccinia of LCMVspecific RNA of appropriate size and polarity . All recombinants express abundant LCMV polypeptide as judged by fluorescent antibody detection . For details see references 23, 24 . nizes LCMV NP The fact that CTL clones 232 and 228 lysed uninfected H-2b targets coated with peptide as 272-293 as efficiently as H-2b targets infected with LCMV further confirmed that this peptide sequence contained the viral epitope being recognized by these clones . Results with CTL clones 31, RG-9, and 39 were similar (data not shown) . The finding that primary splenic CTL gave lower values for target cells coated with peptide as 272-293 when compared with target cells infected with virus indicated that bulk CTL recognize other viral epitopes. For example, specific lysis by H-2b splenic CTL on peptide-coated H-2b target was 26% as compared with 68% for LCMV infected target . In contrast, H-2a splenic CTL failed to lyse~-I-2b targets either coated with peptide or infected with LCMV These observations were recorded in over five separate experiments. When H-2b targets were coated with non-LCMV peptides, no lysis occurred .
To determine the minimal amount ofas 272-293 required to coat targets for CTI, activity, log dilutions of peptide were made, incubated with uninfected "Cr-labeled H-2b targets, and reacted with either CTL clones 232 or 228 . Results of these experiments indicated that half-maximal lysis is achieved with 0.5 ug/ml of the peptide (concentration: 0.25 pM).
The Minimal as Sequence of LCMV Viral Epitope Restricted by H-2b Haplotype is GP 278-286 VENPGGYCL . With a major viral epitope identified in as 272-293, a set of 12 peptides was synthesized (upper 12 peptides, Fig. 1 ) that contained single as deletions from the NH2 or COOH termini. 40 ug of each peptide was used to coat H-2'-uninfected targets, which were then reacted with CTL clones 232 or 228, and the "Cr released was quantitated. Both clones gave equivalent results, indicating that removing as 272-276 or 288-293 had no effect on the efficiency of CTL ac- Exp. 1, the upper 11 peptides
were synthesized as described
by the tea bag method (26) , and
the last peptide was synthesized
with an automated peptide syn-
thesizer. For Exp. 2, the first two
peptides were synthesized by
while the last four were made
by the tea bag method . Results
were equivalent for EST ratios
of 5:1 and 2.5 .1 ; hence, only
those for clone 228 at 2.5 "1 on L H-26 targets are shown. Lysis was specific for LCMV ARM
GP as 272-286 (CTL clone
228: 61%; clone 232 : 55%; clone 31: 46%; clone RG-9 : 64%;
clone 39 : 35%) or larger pep-
tides constructed by addition of
termini. Lysis was restricted to H-26 targets and not H-2d (lysis <8%) targets.
tivity. Thus, peptide as 277-287, GVENPGGYCLT-coated cells were lysed equivalently with corresponding targets coated with as 272-293 (Fig. 1) . When THR in position 287 was removed, lysis occurred but at roughly half the value (35% compared with 65% specific "Cr release). When LEU in position 286 was removed, lysis was abolished. Repeated studies confirmed these observations . In other experiments, six additional peptides were generated (lower six peptides, Fig. 1 ) and their activity on targets with CTL clones showed that deletion ofGLY from position 277 did not abrogate lysis (percent specific lysis by CTL clones 228, 232 GVENPG-GYCLT: 58%, VENPGGYCLT 61%), whereas removal of VAL from as position 278 (ENPGGYCLT: 3%) did. Thus the minimal epitope mapped comprises nine aa, 278-286 VENPGGYCL (Fig. 1) . Site-speck Substitution in as Position 278 Defines Three Sets of CTL Clones. The next series ofexperiments used five CTL clones to focus on the fine structure of the viral epitope for CTL recognition. Since the previous studies indicated that VAL in position 278 was critical for CTL recognition of the viral epitope, a series of amino acid replacements at as 278 were made to dissect peptide-directed CTL activity. As seen in Table II , conservative as substitutions in position 278 VAL to ALA, LEU, or ILE did not alter CTL activity of any of the five clones . Substitution to GLY maintained the activity but at a lesser degree . From these as replacements it is clear that these CTL clones prefer hydrophobic residues. Similarly, substitution of VAL to ASN resulted in only minor alterations in CTL lysis while change of VAL to LYS diminished killing by CTL clone 228 to a much greater extent than the other four CTL clones . Substitution ofVAL to ASP or GLU diminished CTL activity in CTL clones 232, 31, RG-9, and 39 while totally abrogating response of CTL clone 228. Interest- ingly, the CTL activity of clone 39 could be segregated from clones 232, 31, and RG-9 by amino acid substitutions that added aromatic amino acids in position 278. Thus, when aromatic amino acids were added as indicated by substitution of TYR or PHE for VAL, CTL clones 232, 31, and RG-9 retained their lytic activity, whereas, in contrast, CTL clone 39 totally lost activity. Similarly, when TYR or PHE replaced VAL or if a change in polarity occurred (substitution of SER or THR for VAL), CTL clone 228 lost total activity.
We then assayed the ability of CTL clones to lyse H-2b-uninfected target cells coated with concentrations of LCMV GP peptide at 12 .5, 50, or 200 ug/ml. As seen in Fig. 2 , significant lysis by CTL clones 228 and 232 occurred over a wide dose range (from 12 .5 to 200 pg/ml) with the majority of peptide-coated targets (Fig. 2 ). An exception was the lysis by CTL clone 232 of targets coated with LCMV GP peptide containing either SER or THR in residue 278. In this instance lysis occurred at 200 but not 50 or 12.5 wg/ml concentrations . types also contain Lb class I molecules that cannot be separated by these experiments.
Comparison of LCMV GP epitope as 272-293 with Db and Kb sequences (L b has not yet been sequenced) stored in the Dayhoff data bank indicated regions of homology with Db and Kb a1 amino acid sequence 37-52 (Fig. 4) .
Corresponding Db and Kb peptides were synthesized, purified by HPLC (>90% pure), and studied to see whether they interfered with Lysis of H-2b-uninfected targets coated with LCMV GP as 272-293 or infected with LCMV ARM. As seen in Fig. 4 , H-2Db al as 37-52 blocked Lysis in a dose-response manner, but the corresponding Kb peptide that differs from Db by substitution of ARG for PRO in res- idue 50 did not. These results were confirmed in several independent experiments. The Db peptides also blocked killing of H-26 splenic CTL, although some of these are Kb restricted (27) . Discussion These studies provide a detailed fine structural map of a major LCMV ARM glycoprotein epitope recognized by H-2 6 were incubated with varying final concentrations of Db or corresponding Kb peptide (2,500 ; 2,000 ; 1,500; 1,000; 500, 2501tg/ml) . After a 30 min incubation at 37°C the mixture was added to 51Cr-labeled uninfected MC57 cells coated with LCMV ARM peptide at 200 pg/ml and specific lysis was calculated . Similar results were observed with CTL clone 232 . 
linear amino acid sequence VENPGGYCL, as 278-286 of LCMV ARM GP, and its recognition is restricted by the class I H-2 Db gene product. The structure of this peptide bound to a target or within the native protein expressed on virus-infected cells is unknown . Nevertheless, the prevalence of GLY residues coupled with a PRO-GLY is most consistent with a R turn and unlikely to be an a-helical structure (28) . Hence, the current predictive schemes involving an amphipathic a helix (29, 30) as used for T helper lymphocyte epitopes are not consistent with the experimental data obtained here and thus may be of limited value for CTL predictions. An alternative scheme (31) required hydrophobic residues flanked by GLY, charged or polar moieties . This motif is not found in the nine-aa epitope found for LCMV GP although it was helpful for predicting a CTL-influenza virus matrix protein (16) . Clearly more epitopes need to be defined and analyzed before workable rules can be developed for a universally helpful prediction scheme. The approaches reported here coupled with studies in other viral systems (13) (14) (15) (16) (32) (33) (34) should supply the background data required . Interestingly, the viral epitope we mapped according to normalized frequencies of occurrence of as residues in secondary structure (28) suggested a likely R turn, as did as in position 281-283 that contained PRO-GLYGLY, which corresponds to similar sequences observed by the nuclear magnetic resonance studies of Dyson et al. (35, 36) for the formation of reverse turn of peptide fragments of proteins in water solution .
A major function of protein(s) encoded by the MHC is to bind selectively to a part of a viral (foreign) antigen, thereby making it recognizable to CTL. Analysis ofthe three-dimensional structure ofthe human HLA A2 molecule (37, 38) suggests that an MHC molecule has a single binding site for foreign antigen. Within the MHC structure is a groove 25 A long, 10 A wide and 11 A deep capable of accommodating a peptide of 8 to 15 or 16 as in length . The nine-aa epitope described here would fit into that size cavity.
To address the paradox of how a few MHC molecules might be able to handle a large repertoire of viral antigens, several investigators have proposed the existence of meaningful sequence homology between the foreign viral protein and MHC binding site (39) (40) (41) . Accordingly, we found homology between the MHC H-2D 6 restriction molecule in the al domain residues 37-52 and the H-2Kb nonrestriction molecule in the same location with LCMV GP 274-291 . After adding spacers in the MHC molecules between residues 39-40 and 43-44, an alignment occurred where the minimal LCMV CTL epitope VENPGGYCL contained homologous residues -XENP-XY. The Db peptide 37-52 differed from the Kb peptide by one amino acid in position 50 PRO -ARG and blocked CTL killing, while the Kb peptide did not. However, these results did not explain the observations that H-26 splenic CTL (some of which are Kb and perhaps Lb restricted) are effectively blocked and that the single as substitution between Kb and Db maps a few as upstream from the viral epitope (Fig. 3) . Further, the H-26 peptide maps close to but outside the cavity believed to be the HLA-A2 antigen binding site (37, 38) . Conceivably, the activity of the PRO in position 50 of H-2Db may provide a conformational change that empowers this peptide to inhibit competitively viral peptide binding to H-26 MHC molecules expressed on the cell surface. The binding affinities of these peptides are not known nor is their mode of action . Presumably the affinity of the H-2D 6 pep-tide is higher than that of H-2K6 , thereby enabling the former to block recognition of the critical MHC molecule by CTL.
Where and how cells bind peptides is uncertain. It is unlikely that T lymphocytes recognize foreign antigens as natural three-dimensional structures (12) . The mechanism by which such proteins are degraded into short peptides and the cellular pathways they undertake to reach the cell's surface is unclear. Recently a vaccinia/LCMV cDNA expressing the short peptide as 272-293 was constructed and used to infect H-2b cells. These cells processed the truncated protein internally, after which it was recognized by CTL clones 228 and 232 as efficiently as the synthesized LCMV GP 272-293 as peptide added exogenously (Whitton, J. L., M. B. A. Oldstone, unpublished data). Mapping the pathways of these exogenous and endogenous viral reagents within target cells and determining where they associate with MHC may illuminate this problem.
Finally, CTL have a fine specificity allowing discrimination at the single as level . For example, the five CTL clones analyzed here were defined on the basis of similar recognition of the major LCMV glycoprotein epitope restricted by H-2 6 . The size of the nine-aa viral epitope and the ability of a single as deletion from the native structure either at the NH2 or COOH termini suggest that a single interaction with D'' occurred . Yet, the specificities of the clones could be further distinguished by selective as substitutions in position 278 that altered the recognition epitope. Thus, addition ofpolar side chains by substituting SER or THR for VAL segregated these clones into two functional groups . Further, addition of aromatic acids by substitution ofPHE or TYR for VAL further segregated these permissive CTL clones functionally. Dose-response analysis of substituted peptides, especially hydrophobic ones, failed to alter the established recognition pattern even using peptides at 12.5 wg/ml concentration. Fine CTL specificity has been noted previously by Bastin et al. (15) for influenza virus nucleoprotein where a substitution ofASP to GLU in as position 372 aborted class I CTL clone F5 lysis. However the 15-aa size of the peptide epitope was not sufficiently mapped to ascertain whether a single or multiple site of interaction with MHC occurred . Nevertheless, those data and ours strongly suggest that fine CTL specificity appears similar to that exhibited by mAbs and T helper cells (42) as regards recognition of single as changes. The discrimination by these CTL clones will likely be reflected in analysis oftheir corresponding CTL receptors. We are currently pursuing such studies with CTL clones reported here.
Summary
We define a nine-amino acid (aa) sequence of VAL-GLU-ASN-PRO-GLYGLY TYR-CYS-LEU as a major epitope for immunologic recognition of lymphocytic choriomeningitis virus (LCMV) by H-2'-restricted CTL. The epitope was characterized using molecular genetics to bracket broadly and chemistry to precisely identify as residues 278-286 of the viral glycoprotein. The epitope's compostion is characteristic of a reverse (R turn) but not an amphipathic a helix. A series of peptides with a single as substitution in position 278 of VAL with other nonpolar (hydrophobic) amino acids (LEU, ILE, ALA, or GLY) coat targets that are recognized and lysed by CTL clones recognizing this epitope. In contrast, substitution of VAL with either large aromatic amino acids (that add bulk: PHE, TYR) or polar side chains (SER, THR) segregates CTL clones normally recognizing as 278-286 into two groups, one that remains lytic (permissive) despite these changes and another that fails to lyse, indicating CTL can discriminate at a single aa. A change in charge at this position (VAL -ASP or GLU), in general, reduces CTL lysis while a change of VAL to LYS or ASN has minimal affect for four of the five CTL clones analyzed. CTL reactivity with the viral epitope is restricted by the Db but not the Kb of the murine MHC haplotype . A 16-aa peptide of Db that spans al residues 37-52 blocks CTL lysis, whereas the corresponding Kb peptide that differs from Db in a single as in position 50 does not .
